Johnson, M. L., Spira, A., Carbone, D. P., Drake, C., Henick, B., Ingham, M., Caldwell, K., Chan, S., Hart, M., Malloy, A., Maloney, E., Palmer, C., Yang, A., Zhong, M., Basciano, P., Bournazou, E., Ferguson, A. R., & Catenacci, D. (n.d.). 93O First results of phase I/II studies evaluating viral vector-based heterologous prime/boost immunotherapy against predicted HLA class I neoantigens demonstrate CD8 T cell responses in patients with advanced cancers. Annals of oncology, 30, . http://access.bl.uk/ark:/81055/vdc_100098458679.0x000034